Although the biological basis of ITGAV’s contribution to ccRCC tumorigenesis has not yet been fully elucidated, experiments in other cancers have demonstrated an association with well described ccRCC pathways, such as VEGF-mediated neovascularization (Fig. 5C) [45–49]. Here, ITGAV is linked to nonpapillary renal cell carcinoma.